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 Pancreatic adenocarcinoma is the fourth leading cause of cancer death in 
the United States. It is identified by its rapid, invasive progression with a 
profound resistance to treatments such as chemotherapy. Unfortunately, there is a 
lack of information on how to effectively inhibit and control the rapid growth of 
pancreatic tumors, as well as limited information for diagnostics. With current 
methods, pancreatic cancer will continue to prevail as a leading cause of cancer 
death. We propose to study the complexity of pancreatic tumors with a systematic 
and analytical approach. Cancer is an abnormal growth of tissue caused by 
uncontrolled cell division. Observing the growth of these cells would prove to 
have a good basis to monitor the growth of a tumor. Here we create a 3-D 
simulation of tumor growth through mathematical modeling, using data from 
pancreatic cells grown in vitro. Using 3-D models will help to understand 
pancreatic tumors at cellular and molecular levels. 
 The project aims to observe realistic growth of the tumor, accomplished 
from growing tumor cells on a monolayer in order to find parameters for our 3D 
mathematical model. This method will prove more beneficial than testing only on 
a monolayer cell line. Although cell death and the toxicity of drug dosage can be 
tested using a cell monolayer alone, it does not meet the demands of testing drug 
delivery in a realistic tumor environment that the mathematical model would 
provide. The monolayer lacks the dimensions that the drug would have to travel if 
it were delivered to a real in vivo tumor. A possible continuation of this project in 
the future could be to utilize the mathematical based approach to predict optimal 
therapy for the pancreatic tumor in order to develop models that can better test 
patient care for tumors. Computer modeling, another stepping stone through 
mathematical modeling, will possibly lead to testing the toxic effects of drugs on 
a 3-D model through computer modeling will aid in understanding the delivery of 














A ratio of cell death to cell mitosis 
G ratio of cell mitosis to mechanical relaxation 
L diffusion length 
R radius of spheroid tumor 
λM mitosis rate 
λD cell death rate 
λR intrinsic relaxation rate 
∇ del (vector differential) 
u cell velocity 
λP cell-proliferation rate 
λA apoptosis rate 
b measure of mitosis 
n concentration of cell substrate 
  rate at which nutrient is added 
D diffusion coefficient 
λB blood-tissue transfer rate of nutrient 
nB concentration of nutrient in blood 
B measure of vascularization 
µ mobility of cell 











TABLE OF CONTENTS 
APPROVAL PAGE        iii. 
ACKNOWLEDGEMENTS       iv. 
ABSTRACT         v. 
NOMENCLATURE        vii. 
I. INTRODUCTION       1 
II. MATERIALS AND METHODS 
A. Summary        2 
B. Cell Culture       4 
C. Trypan Blue Staining and Cell Counting    5 
D. Mathematical Model Setup     5 
III. DATA AND RESULTS      11 
IV. DISCUSSION        13 















Pancreatic adenocarcinoma is the fourth leading cause of cancer death in 
the United States. Out of the population in the U.S., it was estimated that 37,000 
men and women will die from pancreatic cancer in 2012 alone (statistics from 
National Cancer Institute). Even when the tumor was identified, there was only a 
5% chance of survival [3]. This may lend to the fact that diagnostics fail to locate 
a pancreatic growth until it has grown sufficiently into a malignant tumor. A 
pancreatic tumor is identified by its rapid, invasive progression with a profound 
resistance to treatments such as chemotherapy. It goes unnoticed for months 
without notice due to its deep location, hidden by other organs. It may only 
present itself when it grows large enough and begins to push against surrounding 
tissue, such as intestine, bile ducts, and nervous system [7]. Even then, the initial 
diagnosis can be associated with other illnesses due to the tumor only presenting 
unspecific symptoms (i.e. nausea, difficult motor function). This leaves patients 
with a late stage of correct diagnosis and a smaller survival rate. 
A problem, therefore, seems to be poor understanding of what occurs 
when a tumor becomes malignant. Diagnostics aimed specifically at pancreatic 
cancer have not advanced much. With the rapid growth of pancreatic cancer, 
diagnosticians need to know what stage a tumor has entered in order to quickly 
assess the proper treatment a patient requires. To this end, a link between tumor 
stages and the rapid growth of pancreatic cancer would assist in finding the best 
course of action for a patient after diagnosis of the tumor. 
The proposed project is to use mathematical models to represent tumor 
growth. Unlike observing growth of cancer through monolayers, this model would 
allow us to understand the more complex arrangement of tumor cells as they 
interact [1], [2]. This is a relatively new method for observing cancer growth. This 
provides a better way of studying cellular interactions and would represent an in 
vivo environment. It is believed that this will provide a guideline to identify when 
a tumor mass is benign or malignant [5]. 
 
II. Materials and Methods 
A. Summary 
The mathematical model for the tumor will represent a tumor mass that grows in 
an avascular spheroid. Like cells growing on a monolayer, the avascular spheroid 
will only grow from oxygen and nutrients (from growth factors of the cell media) 
through diffusion instead of a blood supply. For a tumor spheroid, cells interact 
by adhering to each other and continue its growth. The outer cells of the spheroid 
will proliferate while the interior cells die to form a necrotic core due to a lack of 
nutrients. The distance oxygen and nutrients will usually travel is approximately 
100µm before being absorbed by cells, limiting the size of an avascular tumor. 
For the mathematical models, the tumors are limited to 500µm to 2000µm [20]. 
Multicellular spheroid models are developed in vitro to observe its interaction 
with the environment and the cell-cell interaction of the spheroid [7], [8], [9], 
[10], [11], [12]. Although it’s usually vascular tumors that demonstrate irregular 
shapes, avascular spheroids begin to show different morphologies as well [4]. 
Metastasis can be monitored using mathematical models to observe when tumors 
begin to bud and branch out from a typical avascular spheroid shape [5]. 
Early continuum models [13], [14] were developed for tumor growth for the 
diffusion of nutrients. Other studies take into account conditions of a tumor for in 
vivo, such as immune response [15], mitotic inhibitor [15], [38], apoptosis [16], 
and growth stability [17]. The important part of a continuum model is also to 
observe the boundary [39], [40], identified by our mathematical equations. The 
boundary may be either expanding or reached its estimated maximum diameter. 
Morphological stability is identified by the tumor boundary [41], [42]. 
Computer simulations of tumor growth demonstrate how the continuum tumor 
model works [18]. Linear analyses and spherical geometries are limited, requiring 
a nonlinear model. A complex tumor has morphologies that are taken into account 
by an improved continuum tumor model. Through the study for computer models, 
tumor evolution is described by dimensionless parameters. These parameters are 
related to mitosis rate, apoptosis rate, cell mobility, and cell adhesion, which will 
be discussed further on through mathematical equations relating to the tumor 
model. For avascular tumors, these parameters govern the morphology of the 
tumor, which is an advantage of the continuum model. At a certain point, when 
these parameters are scaled, the mathematical model is able to differentiate 
noninvasive tumor growth to unstable, infiltrative growth [18]. This suggests that 
the parameters used for the model to identify the morphology can also be used to 
identify its state of invasion. While normal spheroid tumors are limited to a 
certain size and potential infiltration, morphological instability increases the 
chance for invasion without angiogenesis. More oxygen and nutrients are also 
supplied to aid a tumor’s invasion by increasing surface area from budding and 
branching cells of the spheroid. Instability would lead to complex shapes from 
spheroid budding which would have branches of cells with high nutrient diffusion 
and higher cell proliferation. This has been observed when tumors are able to 
bypass limits from diffusion without angiogenesis in avascular tumors [19], [20]. 
 
B. Cell Culture 
MiaPaca2 cells were used to test cell growth for pancreatic cancer cells. The cells 
were cultured using DMEM (Dulbecco’s Modified Eagle Media; 10% FBS, 1% 
L-glutamine) cell media. 6-well plates were seeded with MiaPaca2 cells. Each 
well was plated with 30,000 cells in 2.5mL of the cell/media mix (1,200 
cells/mL). 24 wells were filled, totaling four 6-well plates. The well plates were 
placed into the incubator (37˚C, humidified 17% CO2) for 24 hours to allow cells 
to attach and grow on the wells. 
C. Trypan Blue Staining and Cell Counting 
After 24 hours, the media was aspirated from the first four wells and 1mL of PBS 
was added to the wells to wash the bottom. PBS was aspirated and added two 
more times to complete the wash. After the third wash and aspiration, 0.5mL of 
trypsin was added to the four wells and placed back in the incubator for 
approximately five minutes to detach the cells from the bottom. A pipette was 
used to evenly mix the detached cells into the media of the wells. 100mL was then 
taken from each well and pipetted into individual centrifuge capsules. 100mL of 
trypan blue was added to the capsules, diluting it by a factor of two. Using a 
hemocytometer, the cell counts of each capsule were counted, giving four cell 
counts (n=4), counting the living cells (white) and dead cells (blue). This was 
repeated at 48hr, 60hr, and 72hr intervals, counting cells from four wells each 
time (n=4). 
 
D. Mathematical Model Setup 
Following the design of a continuum model [18], it’s assumed that the cell density 
of the proliferating cells is constant. Therefore, mass changes correspond to 
volume changes. Defining u to be the cell velocity, volume change is: 
∇ · u = λp         (1) 
where λp is the cell-proliferation rate, defined by: 
λp = bn − λA         (2) 
where n denotes the concentration of a cell substrate (e.g. oxygen or glucose). λp 
corresponds to proliferation through mitosis while λA is the rate of volume loss 
due to apoptosis (programmed cell death). Here, λA is the rate of apoptosis and b 
is a measure of mitosis. 
Since the rate of diffusion of oxygen and nutrients is much faster (e.g. ∼1 min−1) 
than the rate of cell proliferation (e.g. ∼1 day−1), the substrate may be regarded to 
be in a steady state for a given tumor morphology (e.g. [21, 18, 22, 14]). This 
gives: 
0 = D∇2n +          (3) 
where   is the rate at which nutrient is added to the tumor, described by: 
  = λB(nB − n) – λn        (4) 
Here, λB is the blood-tissue transfer rate of nutrient, nB is the concentration of 
nutrient in the blood and λ is the rate of consumption of nutrient by the tumor 
cells. λn describes nutrient uptake by the tumor cells. It is subtracted from the 
source of nutrient of the vasculature to give the rate of nutrient given. In this 
simplified model, the vasculature is assumed to be uniform, and vascular growth 
is associated with a bulk source of oxygen and nutrients. Growth is limited by the 
diffusion of the cell substrates according to this model. 
To determine the cell velocity, Darcy’s law may be used as the constitutive 
assumption [21], [18], [22], [13]: 
u = −µ∇P         (5) 
where P is the oncotic (solid) pressure and µ is a mobility that reflects the 
combined effects of cell–cell and cell–matrix adhesion. Alternatively, the velocity 
may be determined using the Stokes equations [23], [24], [25], [26] or the Darcy-
Stokes (Brinkman) equations [27]. Models of viscoelasticity [28], 
elastoviscoplasticity [29] and soft tissue may also be used. 
The boundary conditions of the tumor [18] may be set up by: 
(n) = n
∞
         (6) 
(P ) = γ κ         (7) 
where the pressure boundary condition (7) reflects the influence of cell–cell 
adhesion through the parameter γ and κ. Together, these two terms make the local 
total curvature. For equation (6), assume n
∞
 is constant so that outside the tumor, 
the nutrient is uniform. Nutrient inhomogeneity in the tumor microenvironment in 
2D has been considered [30, 20, 31, 32, 27] and more recently in 3D [33], [34], 
[35]. 
The normal velocity of the tumor boundary [21], [18], [22], [13] is: 
V = −µn · (∇P )        (8) 
Following [21], [18], [22], [13] and others, assume that λ, λA, λB, nB, and b are 
uniform. Following [18], denote  
λM = bn
∞
          (9) 
to be the characteristic mitosis rate, 
λR = µγ LD
−3
          (10) 
to be the intrinsic relaxation time scale, and 
B =  
    
         
          (11) 
to be a measure of the extent of vascularization. Introducing the non-dimensional 
length scale LD = D
1/2
 (λB + λ)
−1/2
 , and time scale λR
−1, a modified concentration   
and pressure p can be defined [18]: 
n = n




) * (p + (1 −  )G + 
    
  
      (13)
 
where G and A [18] measure the relative strength of cell–cell and cell–matrix 
adhesion and apoptosis, respectively: 
G = (λM/λR) * (1 − B)        (14) 
A = (λA/λM – B)/(1 – B)       (15) 
Boundary equations for   and p can be obtained: 
( ) = 1          (16) 
(p) = κ − AG(x2)/2d        (17) 
in a d-dimensional tumor (d = 2, 3). The non-dimensional normal velocity of the 
tumor [18] is: 
V = −n · (∇p) + Gn · (∇ ) – 
    
  
      (18) 
A study of spherically symmetric tumor growth provides insight into the regimes 
of growth described by the model [21], [18], [36]. In this case, the PDEs reduce to 
ODEs in the polar coordinate r. From equation (18) the evolution equation for the 
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       (19) 
For a radially symmetric tumor, |G| rescales time. In all dimensions, unbounded 
growth (R → ∞) occurs if and only if AG is much greater than 0. Three regimes of 
growth are identified [18], and the behavior is qualitatively unaffected by the 
number of dimensions d. 




Note that the special case of avascular growth (B = 0) belongs to this regime. The 
evolution always leads to a stationary state R∞ (if A > 1, then R∞ = 0). This 
behavior is in agreement with experimental observations of in vitro diffusional 
growth [14] of avascular spheroids to a dormant steady state [9], [10]. In the 
experiments, however, tumors always develop a necrotic core that further 
stabilizes their growth [37]. 
(2) Moderate vascularization: G is much greater than 0 and A is greater than 0, 
where 1 > B (which is much greater than 
  
  
). Unbounded growth occurs from any 
initial radius R0 > 0. The growth tends to be exponential for A < 0 with velocity V 
approaching 
    
 
), as R approaches ∞, and to be linear for A = 0 with velocity V 
approaching G as R approaches ∞. 
(3) High vascularization: G < 0 (where B > 1). For A > 0, growth (V > 0) may 
occur, depending on the initial radius, and is always unbounded; for A < 0 (for 
which cell apoptosis is dominant: 
  
  
 > B), the evolution is always to the only 
stationary solution R∞ = 0. This stationary solution may also be achieved for A > 
0. The stationary radius R∞ is independent of G, and is a solution of V = 0 with V 
from equation (19). 
Mass growth of a spheroid tumor can be monitored by observing the expansion of 
its radius over a period of time. The growth and shape of spheroids grown in vitro 
were governed by specific variables [1]: diffusion length L, the ratio of cell death 
rate to cell mitosis rate A, and the ratio of cell mitosis rate to relaxation rate G. 
The evolving growth of a spheroid [1] can be represented as: 
  
  









      (20) 
Where R is the radius of a tumor, and A is the cell death to cell proliferation ratio. 




         (21) 
As a tumor cell continues to grow, it growth begins to plateau until its radius 
becomes near constant when it doesn’t have a vascular source. Its growth was 
only governed by the nutrients and oxygen that can diffuse through the tumor of 
length L [2]. From Equation 1, and setting the change of R as zero at steady state 
[2], the new equation is: 
  
 
         
                         (22) 
The radius of avascular tumors usually span a radius of 500µm to 2000µm. Using 
these parameters, the death rate to mitosis rate A can be estimated. 
 
III. Data and Results 
A chart was made using the number of cells for 24hr, 48hr, 60hr, and 72hr times.  
 
Figure 1. Living cells were monitored using trypan blue at time intervals 24hr, 48hr, 60hr, and 
72hr. 
 
From the initial slope from the chart of cancer cell growth, shown in Figure 1, the 
mitosis rate (λM) can be calculated. From the chart, λM was approximately 3638.4. 
The cell death rate can thus be calculated by knowing A. 
The radius of avascular tumors usually span a radius of 500µm to 2000µm. Using 



























Figure 2. Relation of death variable, A, and radius of tumor, R, over a 500um to 2000um range 
(setting L=100um, and dividing the actual radius by L, gives a dimensionless range of 2.5 to 10). 
 
From Figure 2, A ranges from: 
0.27  < A < 0.57 
Morphologically stable tumors stay within the definition of G. G regulates a 
stability between mitosis (mass growth) and cell death (destruction of mass). Cell 











































A vs R 
Where I11/2 and I9/2 were Bessel functions, and G (the ratio of cell mitosis rate to 




          (24) 
Using the range of A (0.27 to 0.57) found from Figure 2, the boundaries of G were 
found through Equation 23 and plotted, as seen in Figure 3. The values of A used 
were 0.27 (lowest value), 0.42 (mid-range), and 0.57 (highest value). 
 
Figure 3. Using the boundaries of A (0.27 and 0.57), the area between G-0.27 and G-0.57 was 
morphologically stable for tumor spheroids. 
 
IV. Discussion 
From Figure 3, the stability of the tumor mass is monitored. Following the 
stationary curve in the center, any tumor in the shaded area and to the left is 
morphologically stable. As the radius increases along the stationary curve (when 
  
  
























The increase of the radius as its growth plateaus is an indication that the tumor is 
developing a small G ratio and a larger relaxation rate. This instability was based 
on the spheroid shape of the tumor. As instability increases, the cell adhesion 
forces that keep the tumor together deteriorate and the tumor begins to bud and 
expand. Budding parts of the tumor mark the invasiveness of a tumor, increasing 
the surface area of the tumor for more nutrients and oxygen. As the tumor 
develops a large G ratio, identifying a large mitosis rate, this may indicate 
micrometastasis. Small areas continue to lose cell adhesion as instability (based 
on G) increases [33]. 
A B  
Figure 4. Mathematical models of morphological states. Stable spheroids (A) maintain a spherical 
shape when it is limited by size in its avascular state. When spheroids become unstable (B), the 
surface begins to branch and invade surrounding tissue. The forces that keep the tumor together 
lose effect as the tumor is predicted to metastasize. 
 
 
When analyzing the progression of a tumor, G may be an important identifier to 
tumors that were beginning to metastasize in patients. This work uses cell growth 
data, as demonstrated from the in vitro, to estimate the stability. A dimensionless 
unit G was estimated by 
 
 
. In cases where R can’t be accurately determined, 
   Necrotic core     
   outer boundary     
morphological stability can determine A. Tumor progression may be monitored by 
observing the cell death rate to the cell mitosis rate. Plotting a stationary curve to 
Figure 3 and observing A, as was done above using the data from the MiaPaca 2 
cells in Figure 1, can give observations as to when the tumor shifts to the right of 
the shaded area. When A decreases to a point where cell death was significantly 
less than cell mitosis, the tumor becomes morphologically unstable. Observations 
from in vitro can identify beginning of metastasis using mathematical models. 
When performing in vitro experiments with a patient’s tumor cells, the values of 
A will change, consequently changing the area of the shaded region as well. The 
changing graph according to a patient’s tumor growth and the parameter A will 
indicate what stage a patient is currently. 
Morphological instability is an indicator of metastasis, and observing parameters 
through mathematical models allow practitioners to monitor tumor activity. 
Metastasis was previously thought to derive from malignant tumors [6], but newer 
reconsiderations are being tested for a tumor’s metastatic ability. Models that 
demonstrate branching represent in vivo tumors that are invading surrounding 
tissue. The important concept to take away from this is that branching areas of 
tumor cells have the potential to absorb more nutrients and oxygen, and could 
eventually “pinch off” of the original tumor. 
The aim of these mathematical models and cells grown in vitro is to represent in 
vivo tumor growth. Understanding growth of 3D tumors will benefit 
diagnosticians to make decisions on the best course of treatment for each patient. 
In the future, mathematical models can aid research to counter tumor progression. 
Pancreatic cancer is a particularly aggressive cell line that can be monitored 
morphologically to understand and limit its invasive nature. The aggressive nature 
of pancreatic cancer leads to a high mortality rate in patients. Understanding the 
tumor growth of these cells would not only act as a beneficial model in designing 
drug deliveries and therapies, but alert diagnosticians when a tumor is 
approaching malignant condition. With this goal, mathematical models can be 
designed to predict the 3D nature of cancerous tumors, as well as its growth and 
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